News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
All Stories
News
CRISPR-Based ALS Treatment Being Developed by Scribe and Biogen
October 9, 2020
Genetic Engineering & Biotechnology News
Read Now
Press Release
CRISPR-Based ALS Treatment Being Developed by Scribe and Biogen
October 9, 2020
Genetic Engineering & Biotechnology News
Read Now
News
Biogen teams up with gene-editing startup Scribe on ALS programme
October 8, 2020
Pharma Phorum
Read Now
Press Release
Biogen teams up with gene-editing startup Scribe on ALS programme
October 8, 2020
Pharma Phorum
Read Now
News
Doudna Spin Out Scribe, Partners with Biogen on CRISPR-Based Treatment for ALS
October 8, 2020
Inside Precision Medicine
Read Now
Press Release
Doudna Spin Out Scribe, Partners with Biogen on CRISPR-Based Treatment for ALS
October 8, 2020
Inside Precision Medicine
Read Now
News
Scribe, Biogen Partner to Develop Gene Therapy for ALS, Other Neurological Diseases
October 8, 2020
ALS News Today
Read Now
Press Release
Scribe, Biogen Partner to Develop Gene Therapy for ALS, Other Neurological Diseases
October 8, 2020
ALS News Today
Read Now